Easotic

RSS

hydrocortisone aceponate / miconazole nitrate / gentamicin sulfate

Authorised
This medicine is authorised for use in the European Union.

Overview

Easotic is a veterinary medicine used to treat dogs that suffer from acute or recurrent episodes of ear infections (otitis externa). It contains three active substances: hydrocortisone aceponate, miconazole nitrate and gentamicin sulphate.

This EPAR was last updated on 24/02/2021

Authorisation details

Product details
Name
Easotic
Agency product number
EMEA/V/C/000140
Active substance
  • gentamicin sulfate
  • hydrocortisone aceponate
  • miconazole nitrate
International non-proprietary name (INN) or common name
  • hydrocortisone aceponate
  • miconazole nitrate
  • gentamicin sulfate
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QS02CA03
Publication details
Marketing-authorisation holder
Virbac S.A.
Revision
9
Date of issue of marketing authorisation valid throughout the European Union
19/11/2008
Contact address

1ère Avenue 2065 M - L.I.D.
06516 Carros Cedex
France

Product information

21/06/2019 Easotic - EMEA/V/C/000140 - IB/0021

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Otologicals

  • Corticosteroids and antiinfectives in combination

Therapeutic indication

Treatment of acute otitis externa, and acute exacerbation of recurrent otitis externa associated with bacteria susceptible to gentamicin and fungi susceptible to miconazole, in particular Malassezia pachydermatis.

Assessment history

How useful was this page?

Add your rating